Deferred revenues, noncurrent

Name: Pfizer Deferred revenues, noncurrent by Products & Services
Creator: OpenCapital
License: https://www.opencapital.sh/terms

Pfizer·Products & Services·1 segment·Rolls up to Contract Liabilities

Breakdown

Segment	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Paxlovid and Comirnaty	$1.8B	$1.5B	$785M	$977M	$906M	$1B	$826M	$816M
Total	—	—	—	—	—	—	—	—

Paxlovid and ComirnatyView metric